Small cap infant formula exporters gained on Tuesday after big brother Bellamy’s upgraded its revenue and profit guidance.

The $1.5 billion Bellamy’s upgraded expected revenue growth to between 30 and 35 per cent, up from 15 to 20 per cent.

The news pushed up shares (ASX:BAL) by 25 per cent to near 52-week highs.

Small cap infant formula exporters bathed in the after-glow.

Goat milk favourite Bubs (ASX:BUB) gained 5.5 per cent and Wattle Health (ASX:WHA) jumped 4.4 per cent.

WHA share price movements over the past 6 months. Source:
WHA share price movements over the past 6 months. Source:

Bioxyne’s ‘milk formula for the whole family’ also enjoyed a boost — its shares (ASX:BXN) trading up 3 per cent. Bioxyne also launch three new supplement products today.

Major player A2 Milk also got a look-in. It’s shares (ASX:A2M) climbed 5.7 per cent in afternoon trade.

Demand continues to grow in China and other Asian countries for Australia’s clean-and-green baby food products amid the recall of 12 million formula tins in a salmonella scare by French dairy company Lactalis last month.

The sector continues to expand. China-focused JAT Energy (ASX:JAT) already had exposure through its Cobbity Country subsidiary and bought into Golden Koala milk formula late last year.

Its shares have been suspended since mid-December and last closed at 70c.

Daigou retailer AuMake (ASX:AU8) told shareholder late last year it was in active discussions for its own branded products in the lucrative market.